Adherence to HIV antiretroviral therapy among pregnant and postpartum women during the Option B+ era: 12-month cohort study in urban South Africa and rural Uganda

Simple item page
dc.contributor.authorMatthews, Lynn T.
dc.contributor.authorOrrell, Catherine
dc.contributor.authorMwebesa, Bosco Bwana
dc.contributor.authorTsai, Alexander C.
dc.contributor.authorPsaros, Christina
dc.contributor.authorAsiimwe, Stephen
dc.contributor.authorAmanyire, Gideon
dc.contributor.authorMusinguzi, Nicholas
dc.contributor.authorBell, Kathleen
dc.contributor.authorBangsberg, David R.
dc.contributor.authorHaberer, Jessica E.
dc.date.accessioned2022-01-31T15:33:06Z
dc.date.available2022-01-31T15:33:06Z
dc.date.issued2020
dc.description.abstractWe conducted a cohort study to understand patterns of anti-retroviral therapy (ART) adherence during pregnancy, postpartum and non-pregnancy follow-up among women initiating ART in public clinics offering Option B+ in rural Uganda and urban South Africa. We collected survey data, continuously monitored ART adherence (Wisepill), HIV-RNA and pregnancy tests at zero, six and twelve months from women initiating ART in Uganda and South Africa, 2015 to 2017. The primary predictor of interest was follow-up time categorized as pregnant (pregnancy diagnosis to pregnancy end), postpartum (pregnancy end to study exit) or non-pregnancy-related (neither pregnant nor postpartum). Fractional regression models included demographics and socio-behavioural factors informed by the Behavioral Model for Vulnerable Populations. We evaluated HIV-RNA at 12 months by ever- versus never-pregnant status. In Uganda, 247 women contributed 676, 900 and 1274 months of pregnancy, postpartum and non-pregnancy-related follow-up. Median ART adherence was consistently ≥90%: pregnancy, 94% (interquartile range [IQR] 78,98); postpartum, 90% (IQR 70,97) and non-pregnancy, 90% (IQR 80,98). Poorer adherence was associated with younger age (0.98% [95% CI 0.33%, 1.62%] average increase per year of age) and higher CD4 cell count (1.01% [0.08%, 1.94%] average decrease per 50 cells/ mm3). HIV-RNA was suppressed among 91% (N = 135) ever-pregnant and 86% (N = 85) never-pregnant women. In South Africa, 190 women contributed 259, 624 and 1247 months of pregnancy, postpartum and non-pregnancy-related follow-up. Median adherence was low during pregnancy, 74% (IQR 31,96); postpartum, 40% (IQR 4,65) and non-pregnancy, 77% (IQR 47,92). Poorer adherence was associated with postpartum status (22.3% [95%CI 8.6%, 35.4%] average decrease compared to non-pregnancy-related follow-up) and less emotional support (1.4% [0.22%, 2.58%] average increase per unit increase). HIVRNA was suppressed among 57% (N = 47) ever-pregnant and 86% (N = 93) never-pregnant women. Women in rural Uganda maintained high adherence with 91% of ever-pregnant and 86% of never-pregnant women suppressing HIV-RNA at 12 months. Women in urban South Africa struggled with adherence, particularly during postpartum follow-up with median adherence of 40% and 57% of women with HIV-RNA suppression at one year, suggesting a crisis for postpartum women with HIV in South Africa. Findings suggest that effective interventions should promote emotional support.en_US
dc.identifier.citationMatthews, LT, Orrell, C., Bwana, MB, Tsai, AC, Psaros, C., Asiimwe, S., ... & Wyatt, M. (2020). Adherence to HIV antiretroviral therapy among pregnant and postpartum women during the Option B+ era: 12‐month cohort study in urban South Africa and rural Uganda. Journal of the International AIDS Society , 23 (8), e25586. https://doi.org/10.1002/jia2.25586en_US
dc.identifier.urihttps://doi.org/10.1002/jia2.25586
dc.identifier.urihttps://nru.uncst.go.ug/xmlui/handle/123456789/1687
dc.language.isoenen_US
dc.publisherJournal of the International AIDS Societyen_US
dc.subjectAdherenceen_US
dc.subjectARVen_US
dc.subjectCohort studiesen_US
dc.subjectGenderen_US
dc.subjectAfrica < Regionen_US
dc.subjectWomenen_US
dc.subjectHIVen_US
dc.titleAdherence to HIV antiretroviral therapy among pregnant and postpartum women during the Option B+ era: 12-month cohort study in urban South Africa and rural Ugandaen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal of the International AIDS Society - 2020 - Matthews - Adherence to HIV antiretroviral therapy among pregnant and.pdf
Size:
331.95 KB
Format:
Adobe Portable Document Format
Description:
Article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences